Shares of Biocorrx Inc. (OTCMKTS:BICX – Get Free Report) crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.34 and traded as low as $0.2230. Biocorrx shares last traded at $0.2230, with a volume of 16,500 shares traded.
Biocorrx Stock Performance
The company has a market capitalization of $6.64 million, a price-to-earnings ratio of -1.86 and a beta of 0.19. The company has a fifty day simple moving average of $0.31 and a two-hundred day simple moving average of $0.34.
Biocorrx (OTCMKTS:BICX – Get Free Report) last announced its quarterly earnings data on Friday, August 14th. The company reported ($0.03) EPS for the quarter, beating analysts’ consensus estimates of ($0.05) by $0.02. The business had revenue of $0.09 million during the quarter, compared to analysts’ expectations of $0.24 million.
Biocorrx Company Profile
BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.
See Also
- Five stocks we like better than Biocorrx
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
- 3 Low-P/E Stocks That Look Cheap as the S&P 500 Trades Near Record Highs
- Travel + Leisure Goes Big—Is It Ready to Rally?
- 2 Biotech Stocks Shaping Up for Major Breakouts
Receive News & Ratings for Biocorrx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biocorrx and related companies with MarketBeat.com's FREE daily email newsletter.
